PDE5A and Priapism: They observed that priapism recurrences were sufficiently resolved with low-dose PDE5 inhibitor therapy and explain this observation by the fact that G6PD deficiency generates a pathophysiologic milieu consistent with aberrant nitric oxide (NO)-signalling and heightened oxidative stress in the corpus cavernosum [19].